Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-517015-73-00Phase 4Completed
Phase 4, randomised, double-blind trial in obesity and Hypoandrogenism (TD) comparing Nebido with Placebo oily solution (2 arms). Primary endpoint: Maximal isometric muscle strength in shoulder muscles (shoulder elevation). Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-517015-73-00.